Vima Therapeutics
PrivateLast Round
Series A
Mar 11, 2026
Total Funding Raised
$140M
Company Overview
Vima Therapeutics is a biotechnology company developing oral therapeutics designed for the treatment of movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vima Therapeutics Comparables
Compare Vima Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Motric Bio | 76% | |
| Addex Therapeutics | 76% | |
| Neurocrine Biosciences | 72% |
Vima Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 11, 2026 | ||||
| Series A | May 29, 2025 |
Vima Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Frazier Life Sciences | Series A |
| Canaan Partners | Series A |
| Atlas Venture | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Apr 24, 2026
Monthly visitors increased 303% MoM, reaching 2.4K.
Recent news
Latest coverage and updates
- attends_eventOct 1, 2026
Vima Therapeutics to present new research at the 2026 International Congress of Parkinson's Disease and Movement Disorders in Korea on Oct '26
Vima Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vima Therapeutics's valuation, stock price, and market status.
Is Vima Therapeutics a public or private company?
Vima Therapeutics is a private company.
What is the current stock price of Vima Therapeutics?
Vima Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vima Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vima Therapeutics worth (valuation)?
Valuation information for Vima Therapeutics is not publicly available.
Can I buy Vima Therapeutics stock?
Vima Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vima Therapeutics's last funding round?
Vima Therapeutics's most recent funding round was Series A on March 11, 2026.
Who are the main investors in Vima Therapeutics?
Key investors in Vima Therapeutics include Frazier Life Sciences, Atlas Venture.
Will Vima Therapeutics IPO soon?
No public IPO plans have been announced for Vima Therapeutics.
How can I track Vima Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vima Therapeutics's shares on secondary markets.